Skip to main content

Champions Oncology, Inc.

corporate_fare Company Profile

Champions Oncology, Inc.

CSBR·NASDAQ·Life Sciences·CIK 0000771856

Champions Oncology, Inc. is a technology-enabled research organization that creates technology solutions for drug discovery and development. The company's research center operates in both regulatory and non-regulatory environments, utilizing a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. A core component of these platforms is the company's proprietary bank of Patient Derived Xenograft (PDX) models. This bank of PDX models is used in advanced in vivo and ex vivo pharmacology platforms to provide insights into therapeutic programs. Champions Oncology currently has approximately 1,500 PDX Models in its TumorBank, which are believed to reflect the characteristics of patients in clinical trials (late stage, pretreated, and metastatic). These tumors are implanted and expanded in mice for future studies and characterization. Additional analytical and pharmacology experimental platforms are available to augment information from studies. The PDX bank is highly characterized at the molecular, phenotypic, and pharmacological levels, contributing a differentiated layer of data to the company's large oncology dataset, referred to as the "Datacenter." The Datacenter combines the company's proprietary dataset with other large publicly available datasets. This dataset currently includes approximately 3,500 molecular datasets (genomics, transcriptomics, proteomics, phosphor-proteomics), approximately 3,000 clinical drug responses, approximately 3,500 in vivo drug responses, and accompanying clinical information on the patients from which they were derived (pre and post tumor sample acquisition of drug treatments and responses, age, gender, ethnicity, tumor stage, tumor grade, location of tumor biopsy, histology, etc.) from the TumorBank. A unique feature of this proprietary dataset is its derivation from a living TumorBank, allowing for continuous characterization over time and increased depth of accumulated data. The breadth and depth of the TumorBank and its associated characterization drive the value of the Datacenter.

Champions Oncology, Inc. (NASDAQ:CSBR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 9 items for CSBR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for CSBR spans 8-K, 10-K, 10-Q.

Recent high-impact activity:

  • Champions Oncology Q1 Revenue Up 8.8%, Margin Jumps to 51%, Adjusted EBITDA Soars
  • Champions Oncology Q1 Revenue Rises 8.8% on Research Services Strength
  • Champions Oncology Swings to a Loss as Cash Burn Accelerates and Runway Narrows
  • Champions Oncology Posts Record $59.4M Annual Revenue and Fourth Consecutive Quarter of Positive Adjusted EBITDA
  • Champions Oncology Q4 Revenue Jumps 12% to $13.8M, Margins Improve on Cost Cuts

Financial Snapshot

Fiscal year ended April 30, 2026
Revenue
$59.42M
Net Income
-$1.18M
Diluted EPS
-$0.08
Op. Cash Flow
-$4.47M
Free Cash Flow
-$5.04M
Gross Profit
$28.52M
Operating Income
-$1.14M
Cash & Equivalents
$4.87M
Debt / Equity
0.00×
Net Margin
-2.0%
Shares Outstanding
13.89M sh
Source: 10-K · filed 2026-07-27 · accession 0001628280-26-049834

Short Interest & Short Volume

8.55 days to cover

FINRA reported short interest of 72,290 shares in CSBR as of the October 30, 2026 settlement, a 6.9% decrease from the prior period — about 8.6 days to cover at its recent average daily volume. On November 20, 2026, 33.8% of CSBR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)72,290 shares as of October 30, 2026
Change vs prior period▼ 6.9%
Days to cover8.55 at avg daily volume of 8,455
Daily short volume (FINRA facilities)33.8% of 6,144 shares on November 20, 2026
5-day average short volume26.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$4.34 -1.36% today
52-week range · as of 2026-09-10 $4.34 – $8.74
Market cap
$60.41M
Volume
8.9K (1.2× avg)
3-mo avg 7.2K
Live data · 2026-11-21 06:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CSBR - Latest Insights

CSBR
Sep 10, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.10
Real-time Price: $4.34 info
Change: -$0.7555 (-15%) info
Market Cap: $60.407M info
CSBR
Sep 10, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.10
Real-time Price: $4.34 info
Change: -$0.7555 (-15%) info
Market Cap: $60.407M info
CSBR
Jul 27, 2026, 4:45 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $6.25
Real-time Price: $4.34 info
Change: -$1.91 (-31%) info
Market Cap: $60.407M info
CSBR
Jul 27, 2026, 4:31 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.25
Real-time Price: $4.34 info
Change: -$1.91 (-31%) info
Market Cap: $60.407M info
CSBR
Jul 27, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $4.34 info
Change: -$2.66 (-38%) info
Market Cap: $60.407M info
CSBR
Mar 30, 2026, 1:16 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.88
Real-time Price: $4.34 info
Change: -$1.54 (-26%) info
Market Cap: $60.407M info
CSBR
Mar 12, 2026, 4:56 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.74
Real-time Price: $4.34 info
Change: -$1.40 (-24%) info
Market Cap: $60.407M info
CSBR
Mar 12, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.74
Real-time Price: $4.34 info
Change: -$1.40 (-24%) info
Market Cap: $60.407M info
CSBR
Mar 12, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.74
Real-time Price: $4.34 info
Change: -$1.40 (-24%) info
Market Cap: $60.407M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets